Literature DB >> 31707124

Dosimetric Multicenter Planning Comparison Studies for Stereotactic Body Radiation Therapy: Methodology and Future Perspectives.

Francesca Romana Giglioli1, Cristina Garibaldi2, Oliver Blanck3, Elena Villaggi4, Serenella Russo5, Marco Esposito5, Carmelo Marino6, Michele Stasi7, Pietro Mancosu8.   

Abstract

In this review a summary of the published literature pertaining to the stereotactic body radiation therapy multiplanning comparison, data sharing strategies, and implementation of benchmark planning cases to improve the skills and knowledge of the participating centers was investigated. A total of 30 full-text articles were included. The studies were subdivided in 3 categories: multiplanning studies on dosimetric variability, planning harmonization before clinical trials, and technical and methodologic studies. The methodology used in the studies were critically analyzed to find common and original elements with the pros and cons. Multicenter planning studies have played a key role in improving treatment plan harmonization, treatment plan compliance, and even clinical practices. This review has highlighted that some fundamental steps should be taken to transform a simple treatment planning comparison study into a potential credentialing method for stereotactic body radiation therapy accreditation. In particular, prescription and general requirements should always be well defined; data analysis should be performed with independent dose volume histogram or dose calculations; quality score indices should be constructed; feedback and correction strategies should be provided; and a simple web-based collaboration platform should be used. The results reported clearly showed that a crowd-based replanning approach is a viable method for achieving harmonization and standardization of treatment planning among centers using different technologies.
Copyright © 2019 Elsevier Inc. All rights reserved.

Mesh:

Year:  2019        PMID: 31707124     DOI: 10.1016/j.ijrobp.2019.10.041

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  IMRT and SBRT Treatment Planning Study for the First Clinical Biology-Guided Radiotherapy System.

Authors:  Daniel Pham; Eric Simiele; Dylan Breitkreutz; Dante Capaldi; Bin Han; Murat Surucu; Seyi Oderinde; Lucas Vitzthum; Michael Gensheimer; Hilary Bagshaw; Alex Chin; Lei Xing; D T Chang; Natalyia Kovalchuk
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

2.  Development of a Monte Carlo based robustness calculation and evaluation tool.

Authors:  Hannes A Loebner; Werner Volken; Silvan Mueller; Jenny Bertholet; Paul-Henry Mackeprang; Gian Guyer; Daniel M Aebersold; Marco F M Stampanoni; Peter Manser; Michael K Fix
Journal:  Med Phys       Date:  2022-05-04       Impact factor: 4.506

3.  Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapy.

Authors:  Mark Ka Heng Chan; Chi-Leung Chiang
Journal:  Strahlenther Onkol       Date:  2020-11-27       Impact factor: 3.621

4.  Automation and integration of a novel restricted single-isocenter stereotactic body radiotherapy (a-RESIST) method for synchronous two lung lesions.

Authors:  Lana Sanford Critchfield; Justin Visak; Mark E Bernard; Marcus E Randall; Ronald C McGarry; Damodar Pokhrel
Journal:  J Appl Clin Med Phys       Date:  2021-05-25       Impact factor: 2.102

5.  Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose.

Authors:  L Wilke; C Moustakis; O Blanck; D Albers; C Albrecht; Y Avcu; R Boucenna; K Buchauer; T Etzelstorfer; C Henkenberens; D Jeller; K Jurianz; C Kornhuber; M Kretschmer; S Lotze; K Meier; P Pemler; A Riegler; A Röser; D Schmidhalter; K H Spruijt; G Surber; V Vallet; R Wiehle; J Willner; P Winkler; A Wittig; M Guckenberger; S Tanadini-Lang
Journal:  Strahlenther Onkol       Date:  2021-07-01       Impact factor: 3.621

6.  Head and neck radiotherapy on the MR linac: a multicenter planning challenge amongst MRIdian platform users.

Authors:  Madalyne Chamberlain; Jerome Krayenbuehl; Janita E van Timmeren; Lotte Wilke; Nicolaus Andratschke; Helena Garcia Schüler; Stephanie Tanadini-Lang; Matthias Guckenberger; Panagiotis Balermpas
Journal:  Strahlenther Onkol       Date:  2021-04-23       Impact factor: 3.621

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.